233 results
8-K
LCTX
Lineage Cell Therapeutics, Inc.
14 Jun 24
Changes in Registrant's Certifying Accountant
5:00pm
scope or procedure, which disagreements, if not resolved to the satisfaction of Withum, would have caused Withum to make reference to the subject matter
8-K
EX-5.1
LCTX
Lineage Cell Therapeutics, Inc.
14 May 24
Other Events
4:39pm
and relied upon originals or copies, certified or otherwise identified to our satisfaction, of the Registration Statement and the Prospectus, the Company’s
424B5
LCTX
Lineage Cell Therapeutics, Inc.
14 May 24
Prospectus supplement for primary offering
4:36pm
of the provisions relating to covenant defeasance and legal defeasance;
additions to or changes in the provisions relating to satisfaction and discharge
424B5
alvocyrfc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
8-K
EX-1.1
rtzzxi4o33n
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-5.1
jrryvwst2blwjymra
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
424B5
qraoo s3e7n56s5
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-5.1
ppe3bojyfu bx
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
8-K
EX-99.1
qrfql26syy csbvnu
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am